Janssen HL - Search Results

1

Hypoxia in head and neck cancer: how much, how important?

Janssen HL, Haustermans KM, Balm AJ, Begg AC. Janssen HL, et al. Head Neck. 2005 Jul;27(7):622-38. doi: 10.1002/hed.20223. Head Neck. 2005. PMID: 15952198 Review.

2

Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.

Hoebers FJ, Janssen HL, Olmos AV, Sprong D, Nunn AD, Balm AJ, Hoefnagel CA, Begg AC, Haustermans KM. Hoebers FJ, et al. Among authors: janssen hl. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1206-11. doi: 10.1007/s00259-002-0888-0. Epub 2002 Jul 23. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192567 Clinical Trial.

3

HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.

Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC. Janssen HL, et al. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1537-49. doi: 10.1016/s0360-3016(02)03935-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459383

4

Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors.

Janssen HL, Hoebers FJ, Sprong D, Goethals L, Williams KJ, Stratford IJ, Haustermans KM, Balm AJ, Begg AC. Janssen HL, et al. Radiother Oncol. 2004 Jan;70(1):91-7. doi: 10.1016/j.radonc.2003.09.012. Radiother Oncol. 2004. PMID: 15036858

5

Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.

Begg AC, Janssen H, Sprong D, Hofland I, Blommestijn G, Raleigh JA, Varia M, Balm A, Van Velthuyzen L, Delaere P, Sciot R, Haustermans KMG. Begg AC, et al. Acta Oncol. 2001;40(8):924-8. doi: 10.1080/02841860152708198. Acta Oncol. 2001. PMID: 11845956 Clinical Trial.

6

Thymidine analogues to assess microperfusion in human tumors.

Janssen HL, Ljungkvist AS, Rijken PF, Sprong D, Bussink J, van der Kogel AJ, Haustermans KM, Begg AC. Janssen HL, et al. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1169-75. doi: 10.1016/j.ijrobp.2005.03.063. Int J Radiat Oncol Biol Phys. 2005. PMID: 15990022

7

Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status.

Sprong D, Janssen HL, Vens C, Begg AC. Sprong D, et al. Among authors: janssen hl. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):562-72. doi: 10.1016/j.ijrobp.2005.09.031. Epub 2005 Dec 15. Int J Radiat Oncol Biol Phys. 2006. PMID: 16343804

8

Increasing functional cure rates after nucleo(s)tide analogue withdrawal: is peg-IFN the answer?

Dongelmans EJ, Sonneveld MJ, Janssen HLA. Dongelmans EJ, et al. Among authors: janssen hla. J Hepatol. 2024 Oct 21:S0168-8278(24)02640-0. doi: 10.1016/j.jhep.2024.10.019. Online ahead of print. J Hepatol. 2024. PMID: 39442889 No abstract available.

9

Prediction of hepatocellular carcinoma and liver-related events in anti-HDV positive individuals.

Patmore LA, Spaan M, Agarwal K, Koc ÖM, Blokzijl H, Brouwer S, van Soest H, van Hulzen AGW, Janssen HLA, Lammers AJJ, Jansen L, Claassen M, de Man RA, Takkenberg RB, van Dijk R, Posthouwer D, Reijnders JGP, Carey I, Sonneveld MJ. Patmore LA, et al. Among authors: janssen hla. Clin Gastroenterol Hepatol. 2024 Oct 7:S1542-3565(24)00868-1. doi: 10.1016/j.cgh.2024.08.036. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39384029 Free article.

10

Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis.

Roberts SB, Choi WJ, Worobetz L, Vincent C, Flemming JA, Cheung A, Qumosani K, Swain M, Grbic D, Ko HH, Peltekian KM, Abrahamyan L, Saini M, Tirona K, Aziz B, Lytvyak E, Invernizzi P, Ponsioen CY, Bruns T, Cazzagon N, Lindor K, Dalekos GN, Gatselis NK, Verhelst X, Floreani A, Corpechot C, Mayo MJ, Levy C, Londoño MC, Battezzati PM, Pares A, Nevens F, van der Meer A, Kowdley KV, Trivedi PJ, Lleo A, Thorburn D, Carbone M, Selzner N, Gulamhusein AF, Janssen H, Montano-Loza AJ, Mason AL, Hirschfield GM, Hansen BE; Canadian Network for Autoimmune Liver disease (CaNAL). Roberts SB, et al. JHEP Rep. 2024 Jul 8;6(10):101168. doi: 10.1016/j.jhepr.2024.101168. eCollection 2024 Oct. JHEP Rep. 2024. PMID: 39380718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

629 results

Search Page

Filters